Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study
Randomized study in people · 1994
- What was studied
- 158 post-stroke rehabilitation patients; 137 assessed after treatment and 88 at 24 weeks
- Main finding
- A 12-week placebo comparison reported an aphasia signal but no demonstrated improvement in activities of daily living. Persistence at 24 weeks was unresolved.
Reported findings and study design
The 158-patient rehabilitation trial found a favorable aphasia analysis at 12 weeks (p=0.02), but no demonstrated daily-living benefit. Only 88 patients were available at 24 weeks, leaving persistence uncertain.
Population or model 158 post-stroke rehabilitation patients; 137 assessed after treatment and 88 at 24 weeks
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Aachen Aphasia Test multivariate comparison | Favored piracetam at 12 weeks | p=0.02 |
| Activities of daily living | No demonstrated treatment effect | |
| Follow-up availability | 158 enrolled; 137 after treatment; 88 at week 24 |
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- Substantial loss to later follow-up limits interpretation.
- Aphasia findings require confirmation and do not establish healthy-person cognitive enhancement.
Source details
Journal article
Europe PMC indexed abstract checked; complete trial methods not reviewed.
Abstract
Sources checked
Citation
Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study Clinical neuropharmacology
Study source ↗ · DOI 10.1097/00002826-199408000-00003 · Bibliography entry · Link to this summary